Meet Acumetis at Asembia ASX26
Acumetis will be attending Asembia AXS Summit 2026, widely recognized as the epicenter of the specialty pharmacy industry. With more than 8,000 attendees, many of whom are senior decision-makers, Asembia is where leaders across pharma, biotech, payer, and specialty pharmacy organizations come together to shape the future of patient access, distribution, and commercialization.
As the industry continues to evolve, organizations are facing increasing pressure to improve access, affordability, and patient experience while navigating complex reimbursement and channel dynamics. Asembia provides a unique opportunity to engage in practical, forward-looking conversations on these challenges.
Why Meet with Acumetis
Acumetis works with leading life sciences organizations to navigate complex access and commercialization challenges with clarity and confidence.
At Asembia, our team will be engaging in conversations focused on:
- Translating strategy into execution across patient access and specialty channels
- Identifying practical opportunities to improve patient access and outcomes
- Navigating evolving payer, policy, and distribution dynamics
- Applying real-world insights to drive better decision-making
Where to Find Us
Acumetis will be attending Asembia AXS Summit throughout the week at the Wynn & Encore.
Our team will be available for scheduled meetings and informal conversations across the conference. If you would like to connect, we recommend booking time in advance as schedules fill quickly during the event.
Key conference dates:
April 26–30, 2026 | Wynn & Encore, Las Vegas
Key Topics We’re Discussing
- Direct-to-Patient (DTP) and Direct-to-Employer (DTE) strategies
- The evolving role of specialty pharmacy and HUB models
- AI’s growing impact on patient access and engagement
- Policy shifts including MFN and pricing reform
- Using real-world data to improve access and outcomes
Explore Our Industry Surveys
We are gathering perspectives across key areas shaping access and commercialization in 2026. Participate in one of our surveys below and receive a summary of insights following the event.
State of Access Survey
Examines how manufacturers are navigating evolving access dynamics, including the impact of pricing and policy changes, shifting payer expectations, and the growing role of alternative access models such as Direct-to-Patient and Direct-to-Employer.
Patient Services Insights & Innovation Survey
Evaluates how organizations are redesigning patient support models, including the balance between HUB and specialty pharmacy, the role of AI and digital tools, and the strategies improving speed to therapy and patient experience.
Launch Excellence & Commercialization Survey
Assesses how companies are adapting go-to-market strategies, including changes in investment across launch phases, approaches to expanding patient identification and diagnosis, and the use of AI and partnerships to drive commercial performance.
Connect with our team onsite at Asembia to preview early insights and discuss what these trends mean for your organization.
Who You’ll Meet From Acumetis
Brian Torres – Senior Partner and Practice Lead, Patient Access and Support Services
Leads patient access and support strategy, advising organizations on program design, partnerships, and commercialization to improve access, coordination, and patient experience.
Swathi Rangan – Partner and Practice Lead, Commercial Strategy
Brings experience leading commercialization strategy and product launches, advising on go-to-market models, innovation, and strategic partnerships across the product lifecycle.
Collin Wolf, PharmD – Director, Client Success
Focuses on patient access and support strategy, helping design and implement programs that improve coordination, access, and the overall patient experience.
Lynne Sager – Principal, Patient Access and Support Services
Brings expert experience shaping patient access and support strategies, specializing in the design and scaling of patient support programs that improve access, coordination, and patient experience.
James Convery – Principal, Global Value and Access
Brings extensive experience across market access, commercialization, and stakeholder strategy, advising on pricing, reimbursement, and integrated approaches across complex healthcare environments.
Morgan Kagel – Principal, Patient Access and Support Services
Supports the design and optimization of patient access programs, with a focus on improving access, coordination, and patient experience.
Sureka Gattu, PhD – Principal, Patient Access and Support Services
Brings expertise across market access, medical affairs, and patient strategy, supporting data-driven decision-making and integrated approaches to patient access and care.
Will Sargent, MBA – Principal, Global Innovations Lead
A strategic marketing and commercial leader focused on driving performance and solving complex commercialization challenges through insight-driven strategy and innovative approaches.
Karl Freemyer – Head of Business Development
Leads business development and client engagement, connecting organizations with strategic solutions across market access, HEOR, and commercialization to support critical decision-making across the product lifecycle.
Chris Grimes-Crompton – Principal, Global Value and Access
Brings global experience across biotech, pharma, and healthtech, supporting the development and commercialization of 20+ medicines. Advises on market access, pricing, and commercialization strategy.